Sichuan Huiyu Pharmaceutical Co., Ltd. (688553.SS)

CNY 15.62

(0.64%)

Revenue Summary of Sichuan Huiyu Pharmaceutical Co., Ltd.

  • Sichuan Huiyu Pharmaceutical Co., Ltd.'s latest annual revenue in 2023 was 920.34 Million CNY , down -38.37% from previous year.
  • Sichuan Huiyu Pharmaceutical Co., Ltd.'s latest quarterly revenue in 2024 Q2 was 289.59 Million CNY , up 20.07% from previous quarter.
  • Sichuan Huiyu Pharmaceutical Co., Ltd. reported a annual revenue of 1.49 Billion CNY in annual revenue 2022, down -18.12% from previous year.
  • Sichuan Huiyu Pharmaceutical Co., Ltd. reported a annual revenue of 1.82 Billion CNY in annual revenue 2021, up 33.69% from previous year.
  • Sichuan Huiyu Pharmaceutical Co., Ltd. reported a quarterly revenue of 241.19 Million CNY for 2024 Q1, down -9.2% from previous quarter.
  • Sichuan Huiyu Pharmaceutical Co., Ltd. reported a quarterly revenue of 319.64 Million CNY for 2024 Q3, up 10.37% from previous quarter.

Annual Revenue Chart of Sichuan Huiyu Pharmaceutical Co., Ltd. (2023 - 2017)

Historical Annual Revenue of Sichuan Huiyu Pharmaceutical Co., Ltd. (2023 - 2017)

Year Revenue Revenue Growth
2023 920.34 Million CNY -38.37%
2022 1.49 Billion CNY -18.12%
2021 1.82 Billion CNY 33.69%
2020 1.36 Billion CNY 92.93%
2019 707.07 Million CNY 1201.68%
2018 54.32 Million CNY 288.45%
2017 13.98 Million CNY 0.0%

Peer Revenue Comparison of Sichuan Huiyu Pharmaceutical Co., Ltd.

Name Revenue Revenue Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 9.65 Billion CNY 90.467%
Yabao Pharmaceutical Group Co., Ltd 2.9 Billion CNY 68.37%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 75.51 Billion CNY 98.781%
Harbin Pharmaceutical Group Co., Ltd. 15.33 Billion CNY 94.0%
Tasly Pharmaceutical Group Co., Ltd 8.54 Billion CNY 89.23%
Zhejiang Medicine Co., Ltd. 7.79 Billion CNY 88.192%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 8.22 Billion CNY 88.807%
Lionco Pharmaceutical Group Co.,Ltd. 196.83 Million CNY -367.582%
Humanwell Healthcare (Group) Co.,Ltd. 24.33 Billion CNY 96.218%
Ginwa Enterprise (Group) Inc. 565.4 Million CNY -62.777%
Joincare Pharmaceutical Group Industry Co.,Ltd. 16.64 Billion CNY 94.471%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 644.97 Million CNY -42.696%
China Animal Husbandry Industry Co., Ltd. 5.4 Billion CNY 82.976%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 860.93 Million CNY -6.901%
Zhejiang Huahai Pharmaceutical Co., Ltd. 8.21 Billion CNY 88.793%
Shanghai Haoyuan Chemexpress Co., Ltd. 1.87 Billion CNY 50.846%
Ningbo Menovo Pharmaceutical Co., Ltd. 1.21 Billion CNY 24.345%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 5.52 Billion CNY 83.337%
Chongqing Taiji Industry(Group) Co.,Ltd 15.43 Billion CNY 94.037%
HPGC Renmintongtai Pharmaceutical Corporation 10.38 Billion CNY 91.142%
Nanjing Well Pharmaceutical Group Co.,Ltd. 1.15 Billion CNY 20.374%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 3.73 Billion CNY 75.354%
Henan Lingrui Pharmaceutical Co., Ltd. 3.31 Billion CNY 72.207%
Shenzhen Chipscreen Biosciences Co., Ltd. 515.78 Million CNY -78.436%
Guizhou Yibai Pharmaceutical Co., Ltd. 2.77 Billion CNY 66.869%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 4.86 Billion CNY 81.093%
Zhongzhu Healthcare Holding Co.,Ltd 580.05 Million CNY -58.665%
Beijing Tongrentang Co., Ltd 17.86 Billion CNY 94.847%
KPC Pharmaceuticals, Inc. 7.62 Billion CNY 87.935%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 845.34 Million CNY -8.873%
North China Pharmaceutical Company Ltd. 10.12 Billion CNY 90.906%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 10.22 Billion CNY 90.997%
Tibet Weixinkang Medicine Co., Ltd. 1.32 Billion CNY 30.416%
China National Medicines Corporation Ltd. 49.69 Billion CNY 98.148%
Zhejiang Hisun Pharmaceutical Co., Ltd. 10.37 Billion CNY 91.128%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 3.13 Billion CNY 70.673%
ChengDu ShengNuo Biotec Co.,Ltd. 430.98 Million CNY -113.544%
Dali Pharmaceuticalco.,Ltd 87.26 Million CNY -954.598%
Changchun BCHT Biotechnology Co. 1.81 Billion CNY 49.198%
Zhejiang Shengda Bio-Pharm Co., Ltd. 727.4 Million CNY -26.525%
Shanghai Jiaoda Onlly Co.,Ltd 291.91 Million CNY -215.275%
Jiang Zhong Pharmaceutical Co.,Ltd 4.32 Billion CNY 78.732%
Mayinglong Pharmaceutical Group Co., LTD. 3.13 Billion CNY 70.659%
Cisen Pharmaceutical Co., Ltd. 4.46 Billion CNY 79.375%
Hunan Warrant Pharmaceutical Co.,Ltd 1.43 Billion CNY 35.765%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 41.39 Billion CNY 97.777%
Jianmin Pharmaceutical Group Co.,Ltd. 4.18 Billion CNY 78.004%
Hunan Fangsheng Pharmaceutical Co., Ltd. 1.62 Billion CNY 43.486%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 3.09 Billion CNY 70.278%
Guobang Pharma Ltd. 5.34 Billion CNY 82.795%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 672.96 Million CNY -36.761%
Kangmei Pharmaceutical Co., Ltd. 4.87 Billion CNY 81.117%
Shandong Buchang Pharmaceuticals Co., Ltd. 13.24 Billion CNY 93.051%
Zhejiang Starry Pharmaceutical Co.,Ltd. 2.17 Billion CNY 57.734%
Henan Taloph Pharmaceutical Stock Co.,Ltd 2.06 Billion CNY 55.537%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 3.79 Billion CNY 75.771%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 3.93 Billion CNY 76.59%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 932.12 Million CNY 1.263%
Shanghai Shyndec Pharmaceutical Co., Ltd. 11.93 Billion CNY 92.287%
Shanghai Yizhong Pharmaceutical Co., Ltd. 360.25 Million CNY -155.472%
Tibet Rhodiola Pharmaceutical Holding Co. 3.09 Billion CNY 70.275%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 671.62 Million CNY -37.033%
CanSino Biologics Inc. 345.18 Million CNY -166.627%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 2.17 Billion CNY 57.668%
Shandong Lukang Pharmaceutical Co.,Ltd. 6.14 Billion CNY 85.027%